Sixty out of 219 fosfomycin-resistant bacteria selected from more than 7400 urinary pathogens in an epidemiological multicentre survey performed in Italy were screened for plasmid genes fosA and fosB conferring fosfomycin resistance. Only five strains, three enterobacteria and two staphylococci, carried plasmids harbouring, respectively, fosA and fosB genes. Fosfomycin resistance in the other isolates was caused by an alteration of the chromosomally encoded GlpT transport system. One strain, Morganella morganii 279, incorporated -glycerolphosphate and its mechanism of fosfomycin resistance needs to be further investigated. Our study showed that PCR amplification is the most accurate, simple and rapid method for epidemiological studies of plasmid-encoded fosfomycin resistance, and that fosfomycin resistance conferred by plasmid genes (both fosA and fosB) accounts for only a low percentage of the fosfomycin-resistant strains.
Introduction
Fosfomycin [L-(cis)-1,2-epoxy propyl phosphonic acid] is an antibiotic active against both Gram-positive and Gramnegative bacteria. It has been extensively used clinically in many countries, such as Spain, Italy, France and Japan.
Fosfomycin enters susceptible bacteria by means of the L--glycerolphosphate ( GP) transport system which is the only gate of entry in almost all sensitive bacteria. 1 Another system of fosfomycin transport in some bacteria, the Uhp system, is active only when induced by glucose 6-phosphate (G6P). 1 As GP is not essential for bacterial growth, chromosomal mutations which modify the expression of this permease lead to fosfomycin resistance. Spontaneous fosfomycin-resistance mutants which emerge frequently under therapy or in vitro usually carry mutations in the chromosomal locus glpT and fail to grow in minimal medium containing GP as the sole carbon source. 1, 2 Fosfomycin acts as a phosphoenol pyruvate (PEP) analogue and irreversibly inhibits the UDP-N-acetyl-glucosamine-3-O-enolpyruvyl transferase (pyruvyl transferase or PT). 1 This enzyme catalyses the first step of peptidoglycan biosynthesis. Thus, mutations which decrease the pyruvyl transferase affinity for fosfomycin give rise to more resistant cells, in spite of the simultaneous increase of its K m for PEP which results in a lower rate of peptidoglycan synthesis. 3 Mutants in this locus seem to be very rare and have not been reported in fosfomycin-resistance clinical isolates.
The transfer of a fosfomycin resistance marker encoded by a plasmid by conjugation was described in 1980. 4 The resistant bacteria actively take up the antibiotic [4] [5] [6] [7] and have a fully sensitive PT enzyme. 8 These bacterial strains harbour plasmid genes which confer fosfomycin resistance. One of these, fosA, has been found in various Enterobacteriaceae, in Pseudomonas spp. and in Acinetobacter spp. 9 The biochemical mechanism of fosfomycin resistance mediated by the FosA protein has been now established. 10, 11 Fosfomycin is inactivated by the opening of its epoxide group and later formation of an adduct between its carbon atom 1 and the sulphydryl group of the cysteine of the tripeptide glutathione (GSH). In fact, Escherichia coli cells containing the FosA protein, but which are unable to synthesize GSH (such as gsh mutants), are fosfomycin sensitive. 10 The fosA gene has not yet been found in Grampositive bacteria, though in some of these, such as Staphylococcus epidermidis and Staphylococcus aureus, small plasmids (2.4-4.1 kbp) bearing a different fosfomycin resistance gene, fosB, 12, 13 have been isolated. The biochemical mechanism of fosfomycin resistance conferred by the fosB gene remains undetermined.
The results of an epidemiological survey performed on 7453 urinary pathogens isolated in three Italian hospitals indicated that fosfomycin resistance had not significantly increased since the drug was first used in the treatment of infectious diseases, ie. around 3.0% after the many years of extensive use in clinics. 14, 15 The aim of the present study
Materials and methods

Bacterial strains and culture conditions
The strains used in this work were selected from over 7400 isolates and were provided by G. Schioppacassi (Zambon Group, Milan, Italy) (Table IA) . They were grown on trypticase soy agar (TSA) (Merck, Darmstadt, Germany). Strains with more strict nutritional requirements were grown on Columbia Mouton medium (BioMérieux, Marcy l'Étoile, France). All strains were stored in 20% glycerol at 20°C. A total of 60 strains, 30 Gram-positive and 30 Gram-negative, were included along with seven controls. The details are shown in Tables 1A and 1B. All staphylococci were identified using the coagulase test (Slidex Staphkit, BioMérieux), DNase agar (Difco, Detroit, MI, USA), API Staph (Bio Mérieux) and ID32 Staph (Bio Mérieux).
MICs of fosfomycin
The MICs were determined by the agar dilution method using a Steers replicator 16 in TSA plates containing increasing concentrations of tromethanol fosfomycin (Zambon Group) and supplemented with 2 mM G6P.
Growth on minimal medium plates
Minimal medium (MM) plates supplemented with 5 mM GP 17 were inoculated to study its utilization as the sole carbon source.
DNA techniques
Plasmid DNA was isolated by a modification of the method of Birnboim & Doly. 18 Restriction endonucleases were supplied by Boehringer Mannheim GmbH (Mannheim, Germany) and used following the manufacturer's instructions. The DNA fragments were separated by slab gel electrophoresis and purified with the Geneclean II kit (BIO101 Inc., Vista, CA, USA) under the conditions specified by the supplier. The DNA sequence was determined by the dideoxy method by using double-stranded plasmid DNA as a template, 19 
Detection of fosA and fosB genes by PCR and hybridization
DNA templates were obtained following the method of García et al. 20 In the Gram-positive bacteria, cultures were also treated with mutanolysin (300 U) in addition to lysozyme.
PCR amplification of fosA used two oligonucleotides as described by García et al. 20 PCR amplification of fosB used primers 5 ATATGATCAAAGGAATAAATC 3 and 5 CATATGAAAATTCATATGAGG 3 which target the 5 and 3 ends of the coding region of fosB, 21 respectively. The amplification reactions were performed, and amplicons detected, as described by García et al., 20 except that for fosB the annealing temperature was 40°C.
The fosA probe used in the hybridization experiments was obtained from pUO003, 22 as a 0.85-kbp BglII-PstI fragment, and the fosB probe was a 0.6-kbp EcoRI-PstI fragment of pAT242. 21 The purified DNA fragments were labelled by random-primed DNA-labelling with digoxigenin-labelled deoxyuridine-triphosphate (commercial kit, Boerhinger Mannheim). Hybridization experiments used either total or plasmid DNA which had been previously transferred from agarose gels to nylon filters (Hybond C, Amersham International) by Southern blotting. 23 Hybridization to the target DNA was carried out overnight at 68°C and 45°C. The filters were then washed under highly stringent conditions. Hybrids were marked with anti-DIG antibodies and developed with the lumiphos 530 substrate before being exposed to an X-ray film.
Assay of GlpT transport system
GP incorporation was assayed with L-[U-
14 C] GP (specific activity 150 mCI/mmol; Amersham International). Overnight cultures grown in trypicase soy broth (TSB) were diluted 40-fold in the same medium and incubated with shaking at 37°C until they reached an optical density ranging from 0.6 to 0.8 at 580 nm. Cultures were harvested by centrifugation (15,300g for 5 min at 10°C), washed with one volume of warm MM and resuspended in one-fifth of their initial volume of MM. Cell suspensions were incubated at 37°C for 10 min before adding 0.2 Ci/mL [ 14 C] GP, and 0.015% (Gram-positive strains) or 0.03% (Gram-negative strains) GP. Samples (0.2 mL; 2) were periodically removed and filtered through membrane filters (0.45 m pore size; Supor-450, Gelman Sciences, Ann Arbor, MI, USA). Filters were washed with 10 mL of distilled water, then dried, and their radioactivity was counted in a liquid scintillation counter.
Inactivation kinetics of pyruvyl transferase (PT) by fosfomycin
Cell extracts were obtained following the method of Gunetileke & Anwar 24 with some modifications. The cells were disrupted in a French press (2000 psig), then ultracentrifuged, and the fraction precipitating in the 50-70% saturated ammonium sulphate range was prepared. 25 The pellets were chromatographed on a DEAE-cellulose column as described by Gunetileke & Anwar. 24 Fractions were collected and concentrated by ultrafiltration in a Centricon-30 ultrafiltration cell (Amicon Inc., Beverly, MA, USA). The PT assay was described by Marquardt et al. 25 except that the reaction mixtures had a total volume of 10 L. Two sets of controls were used as described by Gunetileke & Anwar. 24 To evaluate the sensitivity of the PT enzyme to fosfomycin, the extracts were preincubated for 15 min with the antibiotic (200 M), and with UDP-NAG (0.1 mM), a compound required for enzyme inactivation. 1, 26 Once the inactivation reaction was performed, the condensation reaction was started by adding PEP and UDP-NAG (10 mM). For measuring total PT activity all the reagents, except fosfomycin, were added and incubated under the same conditions. E. coli HB101 27 was used to prepare a positive control of fosfomycin-susceptible PT activity. After incubation for 10 min at 37°C the reactions were stopped with 1 mL of Phosphorus Reagent (Sigma Diagnostics, St Louis, MO, USA) following the manufacturer's instructions.
Determination of fosfomycin-inactivating proteins in cell extracts
Cell extracts were partially purified and subjected to anion exchange chromatography as described by Arca et al. 11 except that the chromatography was carried out in batch and that the matrix-bound protein was eluted with 0.4 M NaCl in pH 8 Tris-HCl buffer and later dialysed against the same buffer.
Fosfomycin inactivation was assayed using two methods -bioassay and fluorimetric detection. Bioassay. The inactivation reaction was started by adding 2 mM glutathione and 1.5 g of fosfomycin to the partially purified extracts. After 2 h at 37°C, the samples were adsorbed onto paper discs containing 200 pmol of G6P, and placed onto TSA plates previously seeded with E. coli ESS. The zones of bacterial growth inhibition were compared with those produced by standard fosfomycin solutions. Fluorimetric detection. The fluorimetric detection was carried out following the method of Arca et al. 11 The FosA protein present in partially purified extracts was also detected by immunoblot (Western) analysis using a FosA specific antiserum as described by García et al.
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Results and discussion
Epidemiological study of plasmid-encoded antibiotic resistance is of great therapeutic value in determining the persistence and spread of antibiotic resistance genes. These studies can be performed using genetic techniques (DNA-DNA hybridization and PCR amplification) and/or biochemical techniques (detection of antibioticinactivating activities and enzyme immunoassay). Both techniques were used by García et al. 20 for the study of fosA plasmid-encoded fosfomycin resistance. On the other hand, genetic studies are at present the only ones available for epidemiological studies of fosfomycin resistance mediated by fosB.
The aim of this work was two-fold; first, to find out how frequently plasmid-borne fosfomycin resistance accounted for resistant strains isolated in Italy, a country where the antibiotic has been used clinically for many years; second, to establish an easy, accurate method for epidemiological studies of the spread of fosfomycin resistance genes. For this purpose, 60 fosfomycin-resistant clinical isolates (Table I) were analysed by DNA-DNA hybridization and PCR.
Our results showed that DNA-DNA hybridizations with the probes available for fosA 22 and fosB 21 exhibit some disadvantages. These probes are larger than the genes and consequently can give false positive results. This was the case with Staphylococcus xylosus 1990, which gave positive hybridization with the fosB probe (Figure 1 ) yet did not give amplification by PCR when using total DNA as a template. When the PCR was performed under less stringent conditions a fragment of 226 bp was generated. We found afterwards that only the 5 upstream oligonucleotide of the fosB gene was needed for the generation of this fragment. The sequence of this fragment revealed a region of about 50 bp which shows a 98% identity with the region upstream from the fosB gene from pAT242 of S. epidermidis used as a probe. 21 Moreover, when this sequence was compared with those contained in the GenBank, it showed a high homology (88-96%) with a noncoding region present in some plasmids of staphylococci (Figure 2) .
On the other hand, fosA genes are carried on large plasmids, 22, 27 and the methods for their purification and transfer to nylon membranes are too time-consuming to be applied to a large number of samples. We therefore used PCR to detect plasmid fosfomycin-resistance genes. Control strains, E. coli(pUO003) [fosA] and E. coli(pAT242) [fosB] yielded an amplified fragment of 434 bp as expected. We have screened by PCR a sample of 60 fosfomycin-resistant clinical isolates from three Italian hospitals and found that only five strains carried fosA or fosB. Three of these strains were enterobacteria (Enterobacter sp. 920, and Enterobacte cloacae strains 148 and 1189) and two were staphylococci (Staphylococcus haemolyticus 1993 and S. haemolyticus 518) (Table I ). These five strains were drug multi-resistant (Table II) .
The locations of the fosfomycin resistance genes were studied by DNA-DNA hybridization with fosA and fosB probes, using total DNA digested with HindIII and undigested plasmid DNA, under high and low stringency conditions. We found that fosB was carried by the smallest plasmid (3.5 kbp) of S. haemolyticus 1993 (Figure 1) . Etienne et al. 13 have also found fosB on small plasmids (2.4-4.1 kbp). The plasmid location of the fosB gene also explains the spontaneous loss of the fosfomycin resistance (at a frequency of 0.5%).
The location of fosA could not be clearly established by hybridization using undigested plasmid DNA, which is probably due to the large size of the plasmids carrying this gene, 22, 28 although hybridization was obtained with a 3 kbp HindIII fragment of total DNA preparation from E. cloacae 1189.
The strains were subjected to studies of fosfomycin inactivation by partially purified extracts in the presence of GSH. Fosfomycin inactivation was assayed both by bioassay and by fluorimetric detection after HLPC separation of the GSH-fosfomycin adduct. Inactivation was detected in E. cloacae 1189. The E. cloacae extracts showed only 1-3% of the specific activity of the control strain, E. coli(pUO003). This result could be explained by assuming that fosA is present in low copy-number in the clinical strain (in contrast to what happens in the control strain), or by a weaker promoter, which results in a lower level of the FosA protein being expressed. This low percentage of FosA activity was consistent with a low level of FosA protein detected immunologically at each stage of partial purification. No fosfomycin inactivation was detected in extracts of S. haemolyticus 1993 by any of the methods assayed.
The mechanism of fosfomycin resistance was studied in four PCR negative strains, E. coli 165, Morganella morganii 279, Enterococcus faecium 1030 and S. xylosus 1990, by different methods: DNA-DNA hybridization, GP uptake, PT enzyme assay and detection of fosfomycin-inactivating activities in partially purified extracts. Only S. xylosus 1990 hybridized with the probes (see above). For GP uptake studies two controls were used: E. coli TG1 (positive control) and E. coli TG1 glpT (negative control: this mutant had been isolated by the method of León et al. (Table I) .
Pyruvyl transferase activity was determined by measuring the UDP-NAG-dependent release of P i from PEP. Because the crude extracts contained nucleotidase and phosphatase activities they had to be partially purified before being suitable for the assays. This was not successful for M. morganii 279 because of a low protein concentration and/or a high nucleotidyl transferase activity. The remaining strains showed a fosfomycin-susceptible PT, and the pattern of PT activity was similar; fosfomycin inactivation was time dependent and was dependent on the UDP-NAG concentration (data not shown). Fosfomycin-inactivating activities were not detected in any of the PCR-negative strains after HPLC separation.
Controversial results were obtained for M. morganii 279, as it has a functional GlpT system for fosfomycin uptake, but no fosA-or fosB-homologous sequences could be found. However, previous experiments with this strain (G. Schioppacassi, personal communication) showed that the levels of intracellular GSH fell to 5% of their initial level when cells were grown in the presence of fosfomycin and that the residual fosfomycin measured in the supernatants also fell to 70.7% of the initial concentration. These data suggest that there could be an inactivation mechanism mediated by GSH in M. morganii 279. We plan to study the basis of the fosfomycin resistance in this strain.
The present work is, to the best of our knowledge, the first combined genetic and biochemical survey of plasmidborne fosfomycin resistance in uropathogenic bacteria and the first time that oligonucleotides which target the 5 and 3 ends of the structural region of fosA and fosB genes have been used for the detection of both types of plasmidencoded fosfomycin resistance by PCR in clinical isolates. Our results show that fosfomycin resistance conferred by plasmids constitutes a low percentage of resistance to this antibiotic in the sample studied. We suggest that PCR is the most sensitive and rapid method for detecting plasmidmediated fosfomycin resistance. 
